For those awards that have been granted a no-cost extension, no annual reporting documents are required at the end of the original project period. The PI will instead submit closeout documents at the end of the modified project period/end of no-cost extension. Please note that Section D of the F-RPPR should include the individuals who worked on the project during the last budget period (i.e., excluding the no-cost extension).
Last week NIH issued updated guidance regarding the initiation and assembly of RPPRs in eRA Commons (NOT-OD-18-202). Delegation Rights In response to user feedback and in line with annual RPPRs, NIH now allows PIs to delegate initation of any type of RPPR (annual, interim, or final) to a program assistant (ASST role in Commons). Please note that OSP still requires all annual, interim, and final RPPRs to be routed to OSP for review and submission. For more information, please review the following blog posts: Annual RPPRs Interim RPPRs F-RPPRs Changes in Decimal Allowances NIH has also announced modifications to the effort reporting section of RPPRs. In an effort to decrease administrative burdens on NIH recipients, the effort reporting section on all RPPRs now allows for the inclusion of decimals. For example, previously if a PD/PI had 20% effort/2.4 calendar months on a project, Commons would require the recipient to round down, i.e. to 2 calendar months, resulting in often inaccurate
OSP recently has received a number of questions regarding interim progress reports. As a friendly reminder, interim progress reports are required if and when a recipient organization has submitted a renewal application on or before the date by which a Final Research Performance Progress Report (Final-RPPR) would be required for the current competitive segment. Interim-RPPRs are submitted through eRA Commons. The submission link will appear under the “Status” tab after the performance period end date has passed. Should the renewal application not receive funding, NIH will treat the Interim-RPPR as the Final-RPPR. As such, please note that the progress report submitted within the renewal application no longer serves as the final progress report in the event the renewal is not funded. Conversely, if the renewal is funded, the Interim-RPPR will serve as the annual performance report for the final year of the previous competitive segment. As with a traditional closeout, all Interim-RPPRs must be submitted via eRA Commons within 120
As you may know, all NIH application, proposal, or report submissions must include the PMC reference number (PMCID) when citing papers that the grantee authored or that arose from the NIH-funded research. It is important to note that the PMCID number differs from the PMID number. PMCID refers to the PubMed Central reference number, while the PMID refers to the PubMed reference number. To put it simply, PubMed Central serves as an index of full-text papers, while PubMed serves as an index of abstracts; therefore, PMCID numbers link to full-text papers, and PMID numbers link to abstracts. Only the PMCID number is relevant to the NIH Public Access Policy. More information regarding this policy can be found on the StarBRITE website or the NIH website. For any questions, please contact Laurie Lebo.
NIH has recently modified its F-RPPR submission process. Please note that, as of April 17, 2018, NIH no longer allows PIs to directly submit F-RPPRs (final technical progress reports). OSP will be updating our official workflow process and communicating it to the larger research community in early May. In the meantime, please route the completed report in Commons to Janette Sagraves in OSP. Please note that this change is effective immediately and applies to all closeouts due Monday, April 30, 2018. Please direct any questions regarding this change to your OSP specialist.
Please note that, for all Interim and Final RPPRs submitted on or after October 1, 2017, the Project Outcomes section is now publicly available via the NIH RePORTER. Outcomes are subject to approval and will only be published upon review and approval by NIH staff. The posted material will not include any proprietary, confidential information or trade secrets. Should staff determine the submitted outcomes are unclear or insufficient, recipients will be required to resubmit the outcomes as additional materials (Final Report Additional Materials [FRAM] for a Final RPPR). For questions or concerns, please consult your OSP specialist or visit our recently published blogs about Interim RPPRs and Final RPPRs, respectively.
Last week NIH issued guidance (NOT-OD-18-107) signifying its intent to strengthen enforcement of current closeout policies. Effective immediately NIH will no longer delay the closeouts of those awards with overdue closeout documents unless the recipient has submitted an acceptable prior approval request to the IC. Barring this prior approval, NIH immediately will begin the unilateral closeout of any award that has not complied with applicable closeout requirements within 120 days of the project end date. NIH publishes a running list of upcoming closeouts on its website. Interested individuals may access due date and required reports information for grants closing within a specified time period by entering VUMC’s Institutional Profile File (IPF) Number–10040927. Please note that the failure to adhere to NIH’s closeout policy may result in corrective actions, denial of future awards, suspension, or termination. For questions or concerns, please contact your OSP specialist.
OSP continues to receive questions regarding changes to NIH closeouts and the submission of F-RPPRs. As a reminder, NIH changed their policy January 1, 2017 (NOT-OD-17-022): Final Progress Reports are now submitted in an eRA Commons module that mirrors the submission process of annual RPPRs. This formatting change significantly streamlines and simplifies the submission process in line with already established, regular procedures, with one notable exception: the progress report included in a Type-2 renewal application no longer takes the place of a final progress report, whether or not the application is funded. NIH now requires submission of an “Interim RPPR” while the Type-2 renewal application is under consideration. If the Type-2 is funded, the submitted Interim RPPR will serve as the annual progress report for the previous competitive segment. If the application is not funded, the Interim RPPR will be considered the institution’s final progress report. Highlights from the Notice are copied below: For NIH, the Final Research Performance Progress